Pfizer Inc (PFE)

32.95
0.41 1.23
NYSE : Health Care
Prev Close 33.36
Open 33.29
Day Low/High 32.95 / 33.45
52 Wk Low/High 29.83 / 35.38
Volume 14.39M
Avg Volume 18.71M
Exchange NYSE
Shares Outstanding 5.95B
Market Cap 198.52B
EPS 1.20
P/E Ratio 24.36
Div & Yield 1.28 (3.80%)

Latest News

Pfizer Becomes #17 Most Shorted Dow Stock, Replacing United Technologies

The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Perrigo leading the charge.

Valeant and Teva Share Similar Ambitions With Similar Pitfalls

Valeant and Teva Share Similar Ambitions With Similar Pitfalls

Here's what you need to know now for Wed., Aug. 9.

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire

All eyes are on Pfizer in the months ahead.

Is the Dow That Big a Deal?

Is the Dow That Big a Deal?

The blue-chip index gets all the attention, but doesn't necessarily deserve it.

Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back

Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back

Allergan's earnings weren't sterling, but with the fourth quarter conventionally standing as their strongest, here's what investors can look forward to.

FDA Advisory Committee Votes In Favor Of XELJANZ® (tofacitinib Citrate) For The Treatment Of Active Psoriatic Arthritis

FDA Advisory Committee Votes In Favor Of XELJANZ® (tofacitinib Citrate) For The Treatment Of Active Psoriatic Arthritis

Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to recommend approval of the proposed dose of tofacitinib for the treatment of adult...

Pfizer Stock Upgraded at BMO on Attractive Risk/Reward, Growth Outlook

Pfizer Stock Upgraded at BMO on Attractive Risk/Reward, Growth Outlook

Analysts at BMO Capital expect 'positive updates' on the company's pipeline that could improve investors' view on the company.

Dow Enters August With a Bang, New Records for Day Five

Dow Enters August With a Bang, New Records for Day Five

Telecoms rise, autos sink.

Pfizer's Weak Viagra, Consumer Sales Drag Down Massive Gains in New Products

Pfizer's Weak Viagra, Consumer Sales Drag Down Massive Gains in New Products

Pfizer post earnings beat.

Dow on Track for Fifth Record Close in a Row, Wall Street Rises

Dow on Track for Fifth Record Close in a Row, Wall Street Rises

Telecoms rise, autos sink.

Jim Cramer on Dow 22,000, Under Armour, Foot Locker, Pfizer and Micron

Jim Cramer on Dow 22,000, Under Armour, Foot Locker, Pfizer and Micron

Jim Cramer weighs in on Tuesday's trending stocks.

Jim Cramer: I'm Confused With Pfizer

Jim Cramer: I'm Confused With Pfizer

They haven't distinguished themselves.

Dow Set to Open at All-Time High as Wall Street Awaits Apple

Dow Set to Open at All-Time High as Wall Street Awaits Apple

Stock futures are higher.

Wall Street Preview: Sprint, Snap and Pfizer in Focus

Wall Street Preview: Sprint, Snap and Pfizer in Focus

U.S. stock futures were pointing to strong gains for Wall Street on Tuesday

Stocks Look to Keep Rally Going, Dow Industrials Close to Milestone

Stocks Look to Keep Rally Going, Dow Industrials Close to Milestone

The Dow Jones Industrial Average is looking at a strong open and possibly could cross the 22,000 milestone today.

Bitcoin Is About to Have the Biggest Moment in Its History: Market Recon

Bitcoin Is About to Have the Biggest Moment in Its History: Market Recon

Soon enough, we'll know where the demand lies.

Oil and Earnings. It's TheStreet's Daily Market Preview

Oil and Earnings. It's TheStreet's Daily Market Preview

Oil major swings to profit as crude prices recover

Dow Explodes, Apple Ahead - 5 Things You Must Know Before the Market Opens Tuesday

Dow Explodes, Apple Ahead - 5 Things You Must Know Before the Market Opens Tuesday

The Dow is poised to open at an all-time high on Tuesday.

Pfizer Reports Second-Quarter 2017 Results

Pfizer Reports Second-Quarter 2017 Results

Pfizer Inc. (NYSE:PFE) reported financial results for second-quarter 2017, increased the midpoint of its 2017 financial guidance range for Adjusted diluted EPS (2) and reaffirmed its 2017 financial guidance range for...

Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff

Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff

A glimpse of what to expect during Tuesday's pre-market.

Novice Trade: Pfizer

Novice Trade: Pfizer

If you like pharma, now is the time to scale into the sector.

Tesla and Apple Better Deliver Big-Time or Look Out Below -- Week Ahead

Tesla and Apple Better Deliver Big-Time or Look Out Below -- Week Ahead

The labor market goes under inspection and Apple releases its earnings report.

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Jim Cramer is bullish on Freeport-McMoRan, Apple Hospitality REIT, and Abbott Laboratories.